Looking to partner for targeted alpha therapy

Our locations


Level 7, Macquarie House, 167 Macquarie Street, Sydney, NSW, 2000, Australia


Lab 186, ATC Building Callaghan Campus, University of Newcastle, University Drive, Callaghan NSW 2308 Australia


Y-Block, Queensland Centre for Advanced Technologies (QCAT), 1 Technology Court, Pullenvale, QLD 4069, Australia


B78 Prescott Laboratories, The Braggs Building, The University of Adelaide, Adelaide, SA, 5005

Get in touch

By sending us a message, you agree to our friendly privacy policy.

Partnership Programs

AdvanCell operates a comprehensive partnership program for taking novel radioligand therapies from the lab through to Phase 1 and beyond.

cGMP Isotope

AdvanCell provides its cGMP isotope to partners removing reliance on external supply chains.


AdvanCell’s in-house manufacturing team and infrastructure ensures CMC development to meet FDA requirements.

Clinical Trials

AdvanCell has deep experience in running clinical trials for radioligand therapies.

Australian Advantage

Australia’s world-leading Nuclear Medicine expertise and infrastructure offers a smooth and competitive path for clinical development.